Background
- Male breast cancer (MaBC) encompasses 1% of all BCs. In a previous work (Trapani et al, SABCS 2023), we reported that MaBC recapitulates a unique mutational repertoire. However, prognostic implications of altered pathways in MaBC vs female BC (FeBC) have not been reported before.
- In this work, we analyzed the prognostic implication of single alterations on MaBC-related survival.